uniQure N.V (NASDAQ: QURE) kicked off on Tuesday, down -0.46% from the previous trading day, before settling in for the closing price of $17.43. Over the past 52 weeks, QURE has traded in a range of $3.73-$17.95.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 302.35% over the past five years. While this was happening, its average annual earnings per share was recorded 36.94%. With a float of $42.40 million, this company’s outstanding shares have now reached $48.74 million.
Let’s look at the performance matrix of the company that is accounted for 480 employees. In terms of profitability, gross margin is -11.39%, operating margin of -716.18%, and the pretax margin is -821.68%.
uniQure N.V (QURE) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of uniQure N.V is 13.00%, while institutional ownership is 82.50%. The most recent insider transaction that took place on Dec 10 ’24, was worth 1,503,000. In this transaction CEO, Managing Director of this company sold 100,000 shares at a rate of $15.03, taking the stock ownership to the 597,915 shares. Before that another transaction happened on Dec 09 ’24, when Company’s CEO, Managing Director sold 3,418 for $7.63, making the entire transaction worth $26,079. This insider now owns 597,915 shares in total.
uniQure N.V (QURE) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.94% per share during the next fiscal year.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Take a look at uniQure N.V’s (QURE) current performance indicators. Last quarter, stock had a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 29.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.96, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -3.31 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
uniQure N.V (NASDAQ: QURE) saw its 5-day average volume 1.34 million, a negative change from its year-to-date volume of 1.65 million. As of the previous 9 days, the stock’s Stochastic %D was 84.07%. Additionally, its Average True Range was 1.47.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 94.37%, which indicates a significant increase from 93.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 303.89% in the past 14 days, which was higher than the 147.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.59, while its 200-day Moving Average is $6.37. Nevertheless, the first resistance level for the watch stands at $18.04 in the near term. At $18.74, the stock is likely to face the second major resistance level. The third major resistance level sits at $19.35. If the price goes on to break the first support level at $16.73, it is likely to go to the next support level at $16.12. Assuming the price breaks the second support level, the third support level stands at $15.42.
uniQure N.V (NASDAQ: QURE) Key Stats
The company with the Market Capitalisation of 841.81 million has total of 48,743K Shares Outstanding. Its annual sales at the moment are 15,840 K in contrast with the sum of -308,480 K annual income. Company’s last quarter sales were recorded 2,290 K and last quarter income was -44,380 K.
